GLP-1 (glucagon-like peptide-1) medications help regulate appetite and blood sugar, so you feel full sooner and crave less
Telehealth consultations throughout your treatment ensure dose adjustments align with your insulin sensitivity improvements, weight loss trajectory, and tolerability profile
A study found that those who use GLP-1 agonists like Ozempic have a little higher risk of getting neovascular age-related macular degeneration
The potential to improve quality of life and reduce treatment side effects is promising, but the lack of definitive evidence and possible risks must not be overlooked
How the compounds compare at a glance Combining longevity compounds in research Because these compounds act on different hallmarks, some study designs pair them for example, a mitochondrial peptide alongside an antioxidant
Acute and chronic pancreatitis can lead to exocrine pancreatic insufficiency (EPI)